These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 20704727)
1. Novel cis-trans interactions are involved in post-transcriptional regulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1 mRNA. Zhang L; Wali A; Fontana JA; Dawson MI; Rishi AK J Mol Signal; 2010 Aug; 5():12. PubMed ID: 20704727 [TBL] [Abstract][Full Text] [Related]
2. Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437. Rishi AK; Sun RJ; Gao Y; Hsu CK; Gerald TM; Sheikh MS; Dawson MI; Reichert U; Shroot B; Fornace AJ; Brewer G; Fontana JA Nucleic Acids Res; 1999 Aug; 27(15):3111-9. PubMed ID: 10454607 [TBL] [Abstract][Full Text] [Related]
3. Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cells. Li XS; Rishi AK; Shao ZM; Dawson MI; Jong L; Shroot B; Reichert U; Ordonez J; Fontana JA Cancer Res; 1996 Nov; 56(21):5055-62. PubMed ID: 8895764 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 gene mediated by cis elements present in the 3'-untranslated region. Rishi AK; Hsu CK; Li XS; Hussain A; Gerald TM; Fontana JA Cancer Res; 1997 Nov; 57(22):5129-36. PubMed ID: 9371514 [TBL] [Abstract][Full Text] [Related]
5. Okadaic acid-mediated induction of the c-fos gene in estrogen receptor-negative human breast carcinoma cells utilized, in part, posttranscriptional mechanisms involving adenosine-uridine-rich elements. Farhana L; Boyanapalli M; Tschang SH; Sun RJ; Hsu CK; Zhang YX; Fontana JA; Rishi AK Cell Growth Differ; 2000 Oct; 11(10):541-50. PubMed ID: 11063127 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways. Liu W; Zhang R Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438 [TBL] [Abstract][Full Text] [Related]
7. p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Fritah A; Saucier C; Mester J; Redeuilh G; Sabbah M Mol Cell Biol; 2005 Mar; 25(6):2419-30. PubMed ID: 15743834 [TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437. Rishi AK; Zhang L; Boyanapalli M; Wali A; Mohammad RM; Yu Y; Fontana JA; Hatfield JS; Dawson MI; Majumdar AP; Reichert U J Biol Chem; 2003 Aug; 278(35):33422-35. PubMed ID: 12816952 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation and functional role of p21Waf1/Cip1 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate. Gorospe M; Shack S; Guyton KZ; Samid D; Holbrook NJ Cell Growth Differ; 1996 Dec; 7(12):1609-15. PubMed ID: 8959328 [TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells. Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334 [TBL] [Abstract][Full Text] [Related]
11. Ets-1 protects vascular smooth muscle cells from undergoing apoptosis by activating p21WAF1/Cip1: ETS-1 regulates basal and and inducible p21WAF1/Cip: ETS-1 regulates basal and inducible p21WAF1/Cip1 transcription via distinct cis-acting elements in the p21WAF/Cip1 promoter. Zhang C; Kavurma MM; Lai A; Khachigian LM J Biol Chem; 2003 Jul; 278(30):27903-9. PubMed ID: 12740370 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma. Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678 [TBL] [Abstract][Full Text] [Related]
13. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation. Kavurma MM; Khachigian LM J Biol Chem; 2003 Aug; 278(35):32537-43. PubMed ID: 12796485 [TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
15. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Wu J; Lingrel JB Oncogene; 2004 Oct; 23(49):8088-96. PubMed ID: 15361832 [TBL] [Abstract][Full Text] [Related]
16. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Liu Y; Martindale JL; Gorospe M; Holbrook NJ Cancer Res; 1996 Jan; 56(1):31-5. PubMed ID: 8548769 [TBL] [Abstract][Full Text] [Related]
17. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage. Menendez JA; Mehmi I; Lupu R Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820 [TBL] [Abstract][Full Text] [Related]
18. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells. Zupanska A; Adach A; Dziembowska M; Kaminska B Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721 [TBL] [Abstract][Full Text] [Related]
19. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation. Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579 [TBL] [Abstract][Full Text] [Related]